# Dova Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dova-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Durham, US
- Website: www.dova.com
- Total disclosed funding: $29M
- Latest round: Series A (Sep 19, 2016)
- Investors on record: 4

## About

Founded in 2005 and based in New Carolina, US, Dova Pharmaceuticals, Inc. (f.k.a AkaRx, Inc.) is a biopharmaceutical company that develops AKR-501, a therapeutic medicine for the treatment of thrombocytopenia.

## Funding rounds

- Series A, Sep 19, 2016, $10M — PBM Capital Group, Perceptive Advisors
- Series A, May 10, 2006, $8.1M — InterWest Partners, Sutter Hill Ventures
- Series A, Nov 30, 2005, $11M — InterWest Partners, Sutter Hill Ventures

## Investors

- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series A
- Sutter Hill Ventures (https://capitalatlas.ai/funds/sutter-hill-ventures) — Series A
- PBM Capital Group (https://capitalatlas.ai/funds/pbm-capital-group) — Series A
- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series A